CVRx

Barostim Therapy for Heart Failure

CVRx offers Barostim therapy, an innovative treatment for symptoms of heart failure. This therapy electrically stimulates baroreceptors in the neck to help improve symptoms, enhance quality of life, and increase exercise capacity in patients. The therapy is supported by clinical data and has been the subject of pivotal trials, such as the BeAT-HF study, which assesses its effectiveness in heart failure patients.

Barostim NEO Device

The company's flagship product, Barostim NEO, is an implantable pulse generator designed to treat heart failure. This device works by delivering electrical impulses to baroreceptors, helping to regulate heart function and alleviate heart failure symptoms. Barostim NEO is a critical component of CVRx's offerings and has shown significant patient benefits in both clinical trials and real-world applications.

Patent and Design Holdings

CVRx holds a robust intellectual property portfolio, including 90 issued patents and registered industrial designs worldwide, with 51 patents in the United States. This extensive patent portfolio underscores the company's commitment to innovation and leadership in the field of heart failure treatment technologies.

Prior Authorization and Reimbursement Support

CVRx provides a prior authorization service to assist healthcare providers with the insurance processes related to Barostim therapy. Additionally, the company offers comprehensive reimbursement support for healthcare professionals. This includes coding and coverage information, as well as claims assistance, to ensure that patients can access and benefit from Barostim therapy with minimal administrative hurdles.

Report inaccurate information

Companies similar to CVRx

Heartbeat Health offers a Virtual-First Cardiology model with same-day diagnostics, televisits, and care programs, leveraging real-time clinical data and device connectivity for nationwide cardiovascular care.

BIOTRONIK is a medical device company specializing in the development and manufacturing of pacemakers, ICDs, CRT systems, and cardiac monitors, all of which are MR conditional.

Abiomed offers advanced heart pumps and cardiopulmonary support systems, providing extensive clinical support and educational resources to healthcare professionals globally.

Cardionomic is a Minneapolis-based company focused on transforming treatment for Acute Decompensated Heart Failure (ADHF) through its investigational Cardiac Pulmonary Nerve Stimulation (CPNS™) System.

IronRod Health, founded in 2016 and headquartered in Phoenix, AZ, provides comprehensive remote patient monitoring services to over 15,000 patients across 13 states in the U.S.

Biotricity is a digital health company that provides a range of remote cardiac monitoring devices and a digital health platform, trusted by over 100,000 patients for enhancing cardiac health.

AtriCure specializes in medical devices for atrial fibrillation and related conditions, offering innovative solutions like the Isolator® Synergy™ Ablation System and AtriClip® devices, with a global presence and a strong focus on clinical science and education.

AliveCor offers remote cardiac solutions, empowering patients and healthcare professionals with AI-enabled ECG sensors and personalized heart data available anytime, anywhere.

Second Heart Assist, based in Salt Lake City, Utah, develops innovative circulatory assist devices, including the 'Whisper' catheter-based pump and 'Freedom' wireless implant, aimed at enhancing heart and renal function.

Trainfes offers a telerehabilitation platform that uses smart sensors and electrical stimulation to help patients with motor paralysis perform exercises at home.